Efficacy of Sovateltide (PMZ-1620) in Patients of Acute Ischemic Stroke
Status:
Recruiting
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
In the present prospective, multicentric, randomized, double-blind, parallel,
saline-controlled phase II clinical study; the investigators plan to evaluate the efficacy of
sovateltide (IRL-1620 or PMZ-1620) therapy along with standard supportive care in patients of
acute ischemic stroke.